1. Home
  2. FEED vs CELZ Comparison

FEED vs CELZ Comparison

Compare FEED & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FEED

ENvue Medical Inc. Common Stock

N/A

Current Price

$0.32

Market Cap

5.6M

Sector

N/A

ML Signal

N/A

Logo Creative Medical Technology Holdings Inc.

CELZ

Creative Medical Technology Holdings Inc.

HOLD

Current Price

$0.67

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEED
CELZ
Founded
2003
1998
Country
United States
United States
Employees
14
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.1M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
FEED
CELZ
Price
$0.32
$0.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
272.7K
341.5K
Earning Date
04-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.08
EPS
N/A
N/A
Revenue
N/A
$6,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.69
52 Week High
$6.09
$6.25

Technical Indicators

Market Signals
Indicator
FEED
CELZ
Relative Strength Index (RSI) 22.80 29.60
Support Level N/A N/A
Resistance Level $0.97 $0.93
Average True Range (ATR) 0.03 0.06
MACD 0.01 0.03
Stochastic Oscillator 1.09 4.67

Price Performance

Historical Comparison
FEED
CELZ

About FEED ENvue Medical Inc. Common Stock

ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

Share on Social Networks: